Join us for an engaging session of the AD/PD™ Live Journal Club, where leading experts discuss cutting-edge research in Alzheimer’s and Parkinson’s disease.
Topic for this session: Sex Differences in Biofluid Biomarkers for Alzheimer’s Disease
This session offers a unique opportunity to deepen your understanding of sex differences in Alzheimer’s disease, access expert insights, and participate in a lively discussion shaping the future of biomarker research.
By attending, you will be able to:
- Explore how biological sex influences Alzheimer’s disease biomarkers, including amyloid-β and tau.
- Understand which biomarkers show sex-specific patterns in disease progression and cognitive decline.
- Learn why sex-specific guidelines are critical for advancing AD diagnosis, treatment, and research.
Moderator
Dr. Anne-Marie de Lange
Neuroscientist and Clinical Psychologist, Queen Mary University of London, University of Oxford
Dr. Anne-Marie de Lange is a Neuroscientist and Clinical Psychologist at Queen Mary University of London and the University of Oxford. Her research focuses on population neuroscience and applied machine learning, integrating neuroimaging, clinical, genetic, and psychosocial data to study brain aging and disease risk, with a particular emphasis on women’s brain health across the lifespan.
Speaker
Dr. Mari Asknes
Postdoctoral Fellow, Department of Geriatric Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway